163 related articles for article (PubMed ID: 21373210)
21. Surgical treatment concepts for patients with pancreatic cancer in Germany--results from a national survey conducted among members of the "Chirurgische Arbeitsgemeinschaft Onkologie" (CAO) and the "Arbeitsgemeinschaft Internistische Onkologie" (AIO) of the Germany Cancer Society (DKG).
Sargent M; Boeck S; Heinemann V; Jauch KW; Seufferlein T; Bruns CJ
Langenbecks Arch Surg; 2011 Feb; 396(2):223-9. PubMed ID: 20711737
[TBL] [Abstract][Full Text] [Related]
22. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
23. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
25. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018.
Liedtke C; Jackisch C; Thill M; Thomssen C; Müller V; Janni W;
Breast Care (Basel); 2018 Jul; 13(3):196-208. PubMed ID: 30069181
[No Abstract] [Full Text] [Related]
26. Being Pregnant and Diagnosed with Breast Cancer.
Loibl S; Han SN; Amant F
Breast Care (Basel); 2012 Jun; 7(3):204-209. PubMed ID: 22872793
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference.
Untch M; Fasching PA; Brucker SY; Budach W; Denkert C; Haidinger R; Huober J; Jackisch C; Janni W; Kolberg-Liedtke C; Krug D; Kühn T; Loibl S; Lüftner D; Müller V; Schneeweiss A; Thill M; Harbeck N; Thomssen C
Geburtshilfe Frauenheilkd; 2021 Jun; 81(6):637-653. PubMed ID: 34168378
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
du Bois A; Schmalfeldt B; Meier W; Sehouli J; Pfisterer J; ; ;
Int J Gynecol Cancer; 2006; 16(5):1756-60. PubMed ID: 17009967
[TBL] [Abstract][Full Text] [Related]
29. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
[TBL] [Abstract][Full Text] [Related]
30. [The Quality Assurance Program of the AGO Organkommission OVAR (QS-OVAR): Pattern of Care and Reality in Germany 2001].
du Bois A; Rochon J; Lamparter C; Pfisterer J
Zentralbl Gynakol; 2005 Feb; 127(1):9-17. PubMed ID: 15702446
[TBL] [Abstract][Full Text] [Related]
31. A systematic overview of chemotherapy effects in breast cancer.
Bergh J; Jönsson PE; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
[TBL] [Abstract][Full Text] [Related]
32. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.
Jackisch C; Harbeck N; Huober J; von Minckwitz G; Gerber B; Kreipe HH; Liedtke C; Marschner N; Möbus V; Scheithauer H; Schneeweiss A; Thomssen C; Loibl S; Beckmann MW; Blohmer JU; Costa SD; Decker T; Diel I; Fasching PA; Fehm T; Janni W; Lück HJ; Maass N; Scharl A; Untch M
Breast Care (Basel); 2015 Jul; 10(3):211-9. PubMed ID: 26557827
[TBL] [Abstract][Full Text] [Related]
33. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
Wagner AD; Thomssen C; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
[TBL] [Abstract][Full Text] [Related]
34. Treatment of elderly ovarian cancer patients in the context of controlled clinical trials: a joint analysis of the AGO Germany experience.
Hilpert F; Wimberger P; du Bois A; Pfisterer J; Harter P
Onkologie; 2012; 35(3):76-81. PubMed ID: 22414969
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
36. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
Pagani O; Senkus E; Wood W; Colleoni M; Cufer T; Kyriakides S; Costa A; Winer EP; Cardoso F;
J Natl Cancer Inst; 2010 Apr; 102(7):456-63. PubMed ID: 20220104
[TBL] [Abstract][Full Text] [Related]
37. Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland.
Dueckelmann AM; Fink D; Harter P; Heinzelmann V; Marth C; Mueller M; Reinthaller A; Tamussino K; Wimberger P; Sehouli J
Arch Gynecol Obstet; 2018 Apr; 297(4):847. PubMed ID: 29445924
[TBL] [Abstract][Full Text] [Related]
38. Advanced Breast Cancer: AGO Recommendations 2022 - Focus on ABC6 Consensus.
Untch M; Fasching PA; Haidinger R; Harbeck N; Jackisch C; Lüftner D; Müller V; Schumacher-Wulf E; Würstlein R; Thomssen C
Geburtshilfe Frauenheilkd; 2022 Oct; 82(10):1044-1054. PubMed ID: 36186150
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer.
Harter P; Beutel B; Alesina PF; Lorenz D; Boergers A; Heitz F; Hils R; Kurzeder C; Traut A; du Bois A
Gynecol Oncol; 2014 Mar; 132(3):537-41. PubMed ID: 24462732
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancer.
du Bois A; Marth C; Pfisterer J; Harter P; Hilpert F; Zeimet AG; Sehouli J
Int J Gynecol Cancer; 2012 Feb; 22(2):182-5. PubMed ID: 22274314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
